PRINCETON GLOBAL ASSET MANAGEMENT LLC Revance Therapeutics, Inc. Transaction History

PRINCETON GLOBAL ASSET MANAGEMENT LLC portfolio value:

$68,000
portfolio value

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 2.5K shares 68K $27 2.5K